How CMS Classifies 2025 General Payments to Physicians: Consulting, Speaking, Meals and Travel
CMS Open Payments separates consulting fees, speaking-related services, food and beverage, and travel and lodging into different categories. These categories describe the reported type of transfer, not its effect on prescribing. To compare pharmaceutical-company payments to physicians, define the company and recipient population before calculating category totals or shares.
Program Year 2025 covers transfers of value made from January 1 through December 31, 2025. CMS first published that year’s data on June 30, 2026, so the program year and publication year are different. This guide explains the categories and the scope choices behind a comparison; it does not present a calculated dollar allocation for a pharmaceutical-company physician subset.
Table of contents
- What the 2025 Open Payments Data Covers
- How to Define Pharma-Company Payments to Physicians
- How CMS Classifies Consulting, Speaking, Meals, and Travel
- How to Compare Categories Within One Scope
- How to Interpret Open Payments Records
- Reporting Thresholds and Data Limitations
- Frequently Asked Questions
- Sources
What the 2025 Open Payments Data Covers
Open Payments is a CMS disclosure program for payments and other transfers of value from reporting entities to covered recipients. CMS separates records into general payments, research payments, and ownership or investment interests. General payments are not made in connection with a research agreement or protocol; research payments and ownership or investment records are separate categories. CMS’s data overview reports $3.92 billion in Program Year 2025 general payments, but that figure includes all recipients and reporting entities. It is not a verified total for pharmaceutical-company payments to physicians.
For a physician-focused general-payment analysis, the population should include CMS-defined physicians only. That definition covers state-authorized doctors of medicine or osteopathic medicine, dental medicine or dental surgery, podiatric medicine, optometry, and chiropractors; medical residents are excluded. Nonphysician practitioners and teaching hospitals are not physicians under this definition. The analysis should also exclude research payments and ownership or investment records.
How to Define Pharma-Company Payments to Physicians
CMS does not supply a single payer label that means “pharmaceutical company.” Its applicable-manufacturer framework covers entities that make covered drugs, devices, biologicals, or medical supplies and can include certain commonly owned entities that provide support to an applicable manufacturer. CMS payment data also includes group purchasing organizations (GPOs). A company name alone therefore does not establish that an entity is a pharmaceutical manufacturer or that every record relates to a drug.
Two analytical approaches are possible:
| Approach | Inclusion rule | What the result describes |
|---|---|---|
| Company-based | Include reporting entities with documented drug or biological-product manufacturing activity during 2025; exclude device-only and GPO-only entities | Eligible physician general payments from the defined companies, including mixed-company payments |
| Product-associated | Apply an explicit drug or biological-product association rule to individual records | Payments associated with the selected product scope, rather than every payment from a company |
These are analyst-defined scopes, not an official CMS “pharma” classification. A mixed drug-and-device manufacturer can qualify for the first approach even when some of its payments concern devices or have no specified product. Its full company total must not be described as drug-specific spending. Record the classification evidence and use the same rule across categories.
If a record names several products, count its amount once. The product list does not allocate the reported amount among those products.
How CMS Classifies Consulting, Speaking, Meals, and Travel
For 2025, the exact CMS categories distinguish the familiar labels readers use for types of pharma payments to doctors. In particular, “speaking” is not one standalone category. CMS lists two separate speaking-related categories. CMS’s nature-of-payment guidance and glossary describe these categories and their scope.
| Reader-friendly label | CMS category | How to read it |
|---|---|---|
| Consulting | Consulting Fee | Payment for a physician’s advice or expertise; CMS notes these arrangements are typically set out in a written agreement. |
| Speaking or training outside continuing education | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | A speaking, training, or education engagement outside a continuing-education program. |
| Speaking or faculty work for medical education | Compensation for serving as faculty or as a speaker for a medical education program | A separate category from the other speaking-related category. |
| Meals | Food and Beverage | Reported food or drink provided as a transfer of value. |
| Travel | Travel and Lodging | Travel-related expenses, which can include airfare, lodging, mileage, or cab fare. |
Other 2025 general-payment natures also belong in the eligible analysis universe. They include Acquisitions; Charitable Contribution; Debt forgiveness; Education; Entertainment; Gift; Grant; Honoraria; Long Term Medical Supply or Device Loan; and Royalty or License. Education and Honoraria remain separate categories. Neither should automatically be folded into a broad speaking total. Any combined reader-friendly group needs a disclosed mapping that preserves the underlying categories.
How to Compare Categories Within One Scope
A category table of dollars, shares, and counts needs the same eligible physician and company population in every row. The program-wide $3.92 billion general-payment total is not the denominator for that narrower subset.
Keep categories outside the headline themes visible. Royalties, grants, and other eligible natures of payment can account for dollars that would otherwise disappear from a consulting-speaking-meals-travel comparison. If those themes are grouped together, their shares need not sum to 100% of all eligible general payments.
Label counts precisely: payment records, the source's number of payments included in those records, and distinct recipients are three different measures. One record can represent several payments, while one recipient can appear in many records.
Hypothetical example: A company reports a consulting fee and reimbursed travel on separate records. Keep each reported category and amount once; do not classify both as consulting just because they relate to the same engagement. The example illustrates interpretation, not a finding about a specific company.
How to Interpret Open Payments Records
A reported value may be a transfer of value rather than cash paid directly to a physician. CMS describes direct payments, indirect payments through an intermediary, and payments designated by a recipient to another party. A meal or travel expense, for example, is not the same as a cash honorarium.
The payment category describes how the reporting entity classified a record; it does not, by itself, explain the full context or establish why the transfer occurred. Disclosure alone does not establish misconduct or prove that prescribing was influenced. Evaluating a potential conflict requires context about the financial relationship and the recipient's role; a category label cannot supply that assessment by itself.
Reporting Thresholds and Data Limitations
CMS’s Program Year 2025 reporting thresholds were $13.46 for an individual small payment or transfer of value and $134.54 in aggregate annual value. A transfer below the individual threshold is generally excluded unless the recipient’s aggregate annual value exceeds the annual threshold, in which case all payments or transfers must be reported. The published data is therefore not a complete inventory of every small-value transfer, including every meal.
CMS publishes full datasets for the previous program year annually on or before June 30 and refreshes the data in January. For a comparison, identify the Program Year 2025 release or refresh used; later corrections can change the published records. A webpage's update date is not the payment date or evidence of a new reporting year. Use the CMS data explorer page to find the public search tools and related data resources.
Frequently Asked Questions
Does Open Payments have one speaking category?
No. For 2025, CMS distinguishes compensation for speaking or faculty work at a venue other than a continuing-education program from compensation for serving as faculty or speaker for a medical education program.
Does the $3.92 billion general-payment figure represent payments from pharma companies to physicians?
No. It is CMS’s total for all Program Year 2025 general payments, across covered recipients and reporting entities. It is not the filtered total for pharmaceutical companies and CMS-defined physicians.
Are reported meals and travel payments necessarily cash paid to a doctor?
No. Open Payments includes transfers of value, which can include food, lodging, airfare, and other expenses, as well as cash payments. Records can also be indirect or designated for another party.
Does a reported payment show that a physician’s prescribing was influenced?
No. A disclosure record alone does not establish prescribing influence or misconduct. It reports a payment or transfer of value under the program’s categories.